Results 271 to 280 of about 4,176,223 (397)
Technical Guidance Standard for Cardiac Rehabilitation
Cardiac rehabilitation refers to the application of a comprehensive medical approach that includes exercise, medication, psychosocial support, nutrition, and behavioral interventions such as smoking cessation and alcohol moderation, to enable patients ...
SHEN Yuqin+14 more
doaj
PGD12 Cost of Prescription Drugs And Cost of Treatment Failure for Sinusitis
B Nadesan+4 more
openalex +1 more source
Drug prescriptions to outpatient children: a review of the literature
A. Clavenna, M. Bonati
semanticscholar +1 more source
Objective Rheumatoid arthritis (RA)–associated anticitrullinated protein antibodies (ACPAs) target various antigens by binding short citrulline amino acid motifs, resulting in heterogeneous ACPA profiles among patients. Here we analyzed ACPA patterns by recognized citrulline motifs in relation to the RA risk factors HLA‐DRB1 shared epitope (SE) alleles
Linda Mathsson Alm+18 more
wiley +1 more source
Patterns of psychotropic drug prescriptions and general practice consultations among community-dwelling older people with dementia during the first two years of the COVID-19 pandemic. [PDF]
Du J+9 more
europepmc +1 more source
Objective Although previous studies show that primary prophylaxis against Pneumocystis jirovecii pneumonia (PJP) is effective in patients with rheumatic diseases receiving immunosuppressive treatment, there is limited evidence regarding the optimal timing for prophylaxis withdrawal.
Ju Yeon Kim+5 more
wiley +1 more source
MGB2 The Utilization And Costs of Prescription Drugs in A Texas Medicaid Managed Care Pilot Program
MT Johnsrud, KA Lawson
openalex +1 more source
Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis
Osteoporosis is a chronic disease, and antiresorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used antiresorptive treatments, bisphosphonates and denosumab, have short‐ and long‐term risks that, coupled with their benefits and other unique characteristics, influence ...
Giovanni Adami, Kenneth G. Saag
wiley +1 more source